Third Rock Ventures Lp - Net Worth and Insider Trading
Third Rock Ventures Lp Net Worth
The estimated net worth of Third Rock Ventures Lp is at least $258 Million dollars as of 2024-09-20. Third Rock Ventures Lp is the 10% Owner of Foundation Medicine Inc and owns about 950,956 shares of Foundation Medicine Inc (FMI) stock worth over $130 Million. Third Rock Ventures Lp is the 10% Owner of Constellation Pharmaceuticals Inc and owns about 2,983,051 shares of Constellation Pharmaceuticals Inc (CNST) stock worth over $101 Million. Third Rock Ventures Lp is also the 10% Owner of Agios Pharmaceuticals Inc and owns about 545,454 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $26 Million. Besides these, Third Rock Ventures Lp also holds CytomX Therapeutics Inc (CTMX) . Details can be seen in Third Rock Ventures Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Third Rock Ventures Lp has not made any transactions after 2018-07-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Third Rock Ventures Lp
Third Rock Ventures Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Third Rock Ventures Lp owns 9 companies in total, including Rhythm Pharmaceuticals Inc (RYTM) , Constellation Pharmaceuticals Inc (CNST) , and CytomX Therapeutics Inc (CTMX) among others .
Click here to see the complete history of Third Rock Ventures Lp’s form 4 insider trades.
Insider Ownership Summary of Third Rock Ventures Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2017-10-04 | 10 percent owner |
| CNST | Constellation Pharmaceuticals Inc | 2018-08-22 | 10 percent owner |
| CTMX | CytomX Therapeutics Inc | 2017-03-27 | 10 percent owner |
 | | 2015-03-24 | 10 percent owner |
| | 2015-05-14 | 10 percent owner |
| | 2014-06-24 | 10 percent owner |
| | 2013-12-16 | 10 percent owner |
| | 2014-02-11 | 10 percent owner |
| | 2014-02-11 | 10 percent owner |
Third Rock Ventures Lp Latest Holdings Summary
Third Rock Ventures Lp currently owns a total of 4 stocks. Among these stocks, Third Rock Ventures Lp owns 950,956 shares of Foundation Medicine Inc (FMI) as of April 7, 2015, with a value of $130 Million and a weighting of 50.58%. Third Rock Ventures Lp owns 2,983,051 shares of Constellation Pharmaceuticals Inc (CNST) as of July 23, 2018, with a value of $101 Million and a weighting of 39.36%. Third Rock Ventures Lp also owns 545,454 shares of Agios Pharmaceuticals Inc (AGIO) as of July 23, 2013, with a value of $26 Million and a weighting of 10.03%. The other 1 stocks CytomX Therapeutics Inc (CTMX) have a combined weighting of 0.03% among all his current holdings.
Latest Holdings of Third Rock Ventures Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FMI | Foundation Medicine Inc | 2015-04-07 | 950,956 | 137.00 | 130,280,972 |
| CNST | Constellation Pharmaceuticals Inc | 2018-07-23 | 2,983,051 | 33.99 | 101,393,903 |
| AGIO | Agios Pharmaceuticals Inc | 2013-07-23 | 545,454 | 47.38 | 25,843,611 |
| CTMX | CytomX Therapeutics Inc | 2017-03-27 | 59,777 | 1.17 | 69,939 |
Holding Weightings of Third Rock Ventures Lp
Third Rock Ventures Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 3,976,278 shares on April 7, 2015, which brought Third Rock Ventures Lp around $199 Million.
According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Constellation Pharmaceuticals Inc (CNST) over the past 5 years. The most-recent trade in Constellation Pharmaceuticals Inc is the acquisition of 266,667 shares on July 23, 2018, which cost Third Rock Ventures Lp around $4 Million.
According to the SEC Form 4 filings, Third Rock Ventures Lp has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 0 shares on July 23, 2013, which brought Third Rock Ventures Lp around $0.
More details on Third Rock Ventures Lp's insider transactions can be found in the Insider Trading History of Third Rock Ventures Lp table.Insider Trading History of Third Rock Ventures Lp
- 1
Third Rock Ventures Lp Trading Performance
GuruFocus tracks the stock performance after each of Third Rock Ventures Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Third Rock Ventures Lp is -42.73%. GuruFocus also compares Third Rock Ventures Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Third Rock Ventures Lp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Third Rock Ventures Lp's insider trading performs compared to the benchmark.
Performance of Third Rock Ventures Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.31 | | | | | |
| Relative Return to S&P 500(%) | -13.09 | | | | | |
Third Rock Ventures Lp Ownership Network
Third Rock Ventures Lp Owned Company Details
What does Rhythm Pharmaceuticals Inc do?
Who are the key executives at Rhythm Pharmaceuticals Inc?
Third Rock Ventures Lp is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , Chief Technical Officer Joseph Shulman , and Corporate Controller & CAO Christopher Paul German .
Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary
Over the past 18 months, Third Rock Ventures Lp made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 171,662 shares made by Joseph Shulman , a net sale of 78,894 shares made by Jennifer Chien , and a net sale of 75,787 shares made by Pamela J. Cramer .
In summary, during the past 3 months, insiders sold 191,981 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 191,981 shares. During the past 18 months, 583,578 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 583,578 shares.
Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rhythm Pharmaceuticals Inc Insider Transactions
Third Rock Ventures Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Third Rock Ventures Lp. You might contact Third Rock Ventures Lp via mailing address: 29 Newbury Street, Suite 401, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
